Cartesian Therapeutics(RNAC)
$6.36-0.52 (-7.63%)
RNAC
Cartesian Therapeutics earnings date
$6.36
At close:-0.52 (-7.63%)
Want to see RNAC full AI Analyst Report?
Cartesian Therapeutics (RNAC) Q2 2023 Earnings Report
1,213 Followers
RNAC Q2 2023 EPS Results
- Actual EPS
- -$0.07
- Consensus EPS
- -$0.12
- Beat/Miss
- Beat by +$0.05
- One Year Ago EPS
- $0.06
RNAC Q2 2023 Revenue Results
- Actual Revenue
- $5.25M
- Expected Revenue
- $5.60M
- Beat/Miss
- Missed by -$351.00K
- YoY Revenue Growth
- -86.63%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/17/2023
- Time
- Before Open
- Conference Call
- Thursday, August 17, 2023
RNAC Upcoming Earnings
Cartesian Therapeutics's next earnings date is estimated for March 17, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
RNAC Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
RNAC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 17, 2027 | 2026 (Q4) | -0.91- | -3.46 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.01-0.38 | -1.38 | 72.46% (+1.00) | |
| Aug 06, 2026 | 2026 (Q2) | -0.880.46 | 0.5 | -8.00% (-0.04) | |
| May 07, 2026 | 2026 (Q1) | -0.87-1.46 | -0.68 | -114.71% (-0.78) | |
| Mar 09, 2026 | 2025 (Q4) | -0.85-3.46 | -0.59 | -485.45% (-2.87) | |
| Nov 06, 2025 | 2025 (Q3) | -0.85-1.38 | -1.13 | -22.12% (-0.25) | |
| Aug 07, 2025 | 2025 (Q2) | -0.800.50 | 0.54 | -7.41% (-0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.70-0.68 | -10.5 | 93.52% (+9.82) | |
| Mar 13, 2025 | 2024 (Q4) | -0.83-0.59 | -2.17 | 72.76% (+1.58) | |
| Nov 07, 2024 | 2024 (Q3) | -0.80-1.13 | -1.35 | 16.30% (+0.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
